CENTA Filings — Central Garden & Pet Company - FilingSpy
CENTA
Central Garden & Pet Company
A maker of pet supplies and lawn-and-garden products sold in U.S. stores, with brands like Nylabone dog chews, Kaytee bird and small-animal food, Pennington grass seed, and Amdro pest control. It began in 1980 as Central Garden Supply, a California distributor founded by William Brown, and grew by buying up familiar brands. Fun fact: Amdro's fire ant bait uses "delayed toxicity," so worker ants carry it back to the mound and feed it to the queen, wiping out the whole colony.
Organic sales returned to growth as the Pet Distribution exit reshaped reported revenue, while gross margin hit 35.9%.
Central Garden & Pet's reported fell 8.2%, but that decline was entirely due to the divestiture of its Pet Distribution business; rose 2.4%. expanded 130 to 35.9%, and rose 10.5% to $125.8 million, as the exit of the lower-margin distribution business and cost-savings initiatives lifted profitability. The company is now a higher-margin, less complex business, with a major European acquisition on the horizon.
Key takeaways
Reported fell 8.2% to $882.4 million, driven entirely by the April 2026 divestiture of the Pet Distribution business; excluding this, organic net sales grew 2.4%.
expanded 130 to 35.9%, benefiting from the exit of the lower-margin distribution business and ongoing Cost and Simplicity program initiatives in both segments.
Pet reported sales fell 18.7% to $400.5 million due to the divestiture, but organic Pet sales increased 1.7%.
Section summaries
Management's Discussion and Analysis
Q3 FY2026 net sales fell 8% to $882M on Pet Distribution exit, but organic sales rose 2.4% and gross margin expanded 130 bps to 35.9%.
⌄
Reported declined 8.2% to $882.4M, driven entirely by the April 2026 divestiture of the Pet Distribution business; grew 2.4%.
Pet reported sales fell 18.7% to $400.5M due to the divestiture, while Pet organic sales increased 1.7%.
Garden sales rose 2.9% to $481.9 million, led by volume-driven gains in wild bird feed, controls, and grass seed from new retailer listings.
rose 10.5% to $125.8 million, as the improvement more than offset a 28.9% increase in corporate operating expenses tied to M&A activity and data investments.
The company announced a post-quarter agreement to acquire 80% of European pet supplies leader TRIXIE for up to €400 million, expected to close in the first half of fiscal 2027.
What changed
The Q2 FY2026 watch item on whether the Garden 's 13.0% growth could be sustained was answered: Garden sales rose 2.9% in Q3, a more moderate pace now that the shipment-timing normalization has played out.
The Q2 FY2026 watch item on the underlying decline of 20 (excluding one-time items) was resolved: gross margin expanded 130 basis points to 35.9%, as the exit of the lower-margin distribution business and cost-savings initiatives more than offset the prior quarter's manufacturing-cost and private-label mix pressures.
The Q2 FY2026 watch item on the pet-distribution strategic partnership was settled: the transaction closed in April 2026, reshaping reported results and composition for the quarter.
The Nite Glow litigation remains unresolved, with the company continuing to appeal the $7.2 million judgment entered in October 2025.
What to watch
Whether the organic growth of 2.4% can be sustained or built upon in Q4, particularly in the Pet where rose only 1.7%.
The terms and financing of the announced acquisition of 80% of TRIXIE for up to €400 million, and the impact on and integration costs when the deal closes in the first half of fiscal 2027.
Whether the 35.9% is a new baseline or a peak, as the company laps the initial benefit from exiting the lower-margin distribution business.
The outcome of the appeal of the $7.2 million Nite Glow judgment and whether it results in a cash outflow or a charge beyond what management currently expects.
Garden sales rose 2.9% to $481.9M, led by volume-driven gains in wild bird feed, controls, and grass seed from new retailer listings.
improved 130 to 35.9%, benefiting from the exit of the lower-margin distribution business and cost-simplicity initiatives in both segments.
Corporate operating expense jumped 28.9% to $31.0M, reflecting higher M&A activity costs and investments in data improvement and AI readiness.
The company announced a post-quarter agreement to acquire 80% of European pet supplies leader TRIXIE for up to €400M, expected to close in the first half of fiscal 2027.
Quantitative and Qualitative Disclosures About Market Risk
There has been no material change in our exposure to market risk from that discussed in our Annual Report on Form 10-K for the fiscal year ended September 27, 2025.
⌄
There has been no material change in our exposure to market risk from that discussed in our Annual Report on Form 10-K for the fiscal year ended September 27, 2025.
Central Garden & Pet is appealing a $7.2M judgment in a long-running misappropriation case; no other material proceedings are reported.
⌄
Nite Glow Industries sued Central over flea-and-tick product applicators, alleging patent infringement, breach of contract, and misappropriation of confidential information.
A 2018 jury verdict awarded Nite Glow ~$12.6M; post-trial motions reduced it to $12.4M, and the Federal Circuit later overturned the patent and contract findings.
The Federal Circuit affirmed liability for misappropriation but ordered a new trial on damages limited to 'head start' benefit from the confidential information.
After retrial, the court awarded $5.0M on September 30, 2025, and entered a $7.2M judgment including on October 17, 2025.
Central has appealed the $7.2M judgment and believes it will prevail, but acknowledges litigation uncertainty and possible expense above expectations.
The company states it is not party to any other legal proceedings expected to materially affect its financial position or results of operations.
There have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year ended September 27, 2025.
⌄
There have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year ended September 27, 2025.